chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Day #1- Minimal Localized Right Deltoid Soreness Day #2 12-24 hours post-vaccination-  Myalgias, Affected Arm Lymphalgia in axilla, Fatigue, Elevated Temperature to 100.1 despite Acetaminophen and Ibuprophen.   Night sweats, worsening myalgia throughout night.  Would not have been able to go to work and perform duties (fortunately did not have to work this day or the next) Day #3- Symptoms improving-still myalgias, fatigue, mild-moderate right axillary lymphalgia.
pt recv vax 24FEB97 & 1MAR97 pt died of a cardiac death;f/u was recv from MD:the autopsy showed myocardial fibrosis, so MD concluded the pt must have had a viral myocarditis;
0941 Patient vomited upon leaving vaccine area. Patient stated that she has a needle phobia. Assisted patient to sitting position for assessment. VItals: T 96.6, P 61, BP 110/70, O2 98%. Will monitor for 30 minutes. 1009 Patient states that she is feeling better. Vitals: T 97.2, P 49, BP 110/65, O2 99%.  Educated patient on vitals and low heart rate. Patient states she will follow up with healthcare provider. Patient discharged to friend.
Site: Swelling at Injection Site-Mild, Systemic: tingling numbness, swollen lymph nodes, heavy arm-Mild, Systemic: Lymph Node Swelling-Mild, Systemic: Tingling (specify: facial area, extemities)-Mild, Additional Details: tingling and numbness  at injection site
Sore injection arm (left); This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore injection arm (left)) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore injection arm (left)). At the time of the report, PAIN IN EXTREMITY (Sore injection arm (left)) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications and treatment information were reported.
Patient received dose of COVID19 (Pfizer-BioNTech) past the vial BUD (Beyond Use Date) of 32 days from transfer of deep freeze to refrigeration temperature. BUD date of dose was 1/7/22 at 0900, patient received vaccination on 1/14/22 at approximately 10:30am. When error discovered facility contacted CDC for course of action. At direction of the CDC, patient contacted regarding occurrence to offer re-vaccination of dose. Patient accepted revaccination on 4/27/2022. No adverse side effects or event as result of dose.
The patient received a dose of the vaccine following temperature excursions on unknown dates; No adverse event; This spontaneous report as received from a medical assistant refers to a current 3-month-old patient of unknown gender.  The patient's concurrent conditions, medical history and concomitant medications were not provided.   On an unknown date, the rotavirus vaccine, live, oral, pentavalent (ROTATEQ)  (lot # S013439 with expiration date 03-MAR-2021, lot # S013436 with expiration date 30-JAN-2021, and lot # S006050 with expiration date 12-DEC-2020) underwent a temperature excursion.   Temperature Total Time and LOWEST Temperature BELOW 36°F/2°C (0C) Time frame 7 hours 30 minutes Previous temperature excursion? yes, Total Time and LOWEST Temperature BELOW 36°F/2°C (0C) for 8 hours 30 minutes Was call because of a "data logger"? yes  On an unknown date, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) at a dose of 2 ml (route not provided) as prophylaxis. No adverse events were reported.  This is one of several reports received from the same reporter  This spontaneous report as received from a other health professional refers to a patient of unknown age.    On an unknown date the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot # S006050, 2 milliliter for prophylaxis.       On an unknown date the patient experienced product storage error and no adverse event.    The outcome of product storage error and no adverse event is unknown.   The reporter considered product storage error and no adverse event to be not assessed to Rotavirus Vaccine, Live, Oral, Pentavalent(ROTATEQ).     {Additional information has been requested. / Additional information is not expected.}; Sender's Comments:  US-009507513-2005USA003382: US-009507513-2005USA004545: US-009507513-2005USA004950: US-009507513-2005USA004951: US-009507513-2005USA004952: US-009507513-2005USA004953: US-009507513-2005USA004954: US-009507513-2005USA004955: US-009507513-2005USA004956: US-009507513-2005USA004958: US-009507513-2005USA004959: US-009507513-2005USA004960: US-009507513-2005USA004961: US-009507513-2005USA004962: US-009507513-2005USA004963: US-009507513-2005USA004964: US-009507513-2005USA004965: US-009507513-2005USA004966: US-009507513-2005USA004967: US-009507513-2005USA004968: US-009507513-2005USA004969: US-009507513-2005USA004970: US-009507513-2005USA004971: US-009507513-2005USA004972: US-009507513-2005USA004973: US-009507513-2005USA004974: US-009507513-2005USA004975: US-009507513-2005USA004976: US-009507513-2005USA004977: US-009507513-2005USA004978: US-009507513-2005USA004979: US-009507513-2005USA004980: US-009507513-2005USA004981: US-009507513-2005USA004982: US-009507513-2005USA004983: US-009507513-2005USA004984: US-009507513-2005USA004985: US-009507513-2005USA004986: US-009507513-2005USA004987: US-009507513-2005USA004988: US-009507513-2005USA004989: US-009507513-2005USA004990: US-009507513-2005USA004991: US-009507513-2005USA004992: US-009507513-2005USA004993:
Patient with history of Parkinson's and COPD.  He was brought to the ED by EMS on 12/3/22 for evaluation of weakness. Patient reportedly has been feeling weak since being diagnosed with pneumonia on 11/9/22. He was hospitalized until 11/23/22 and was sent to a rehab center after discharge, and left the rehab center on 12/2/22 (day prior to presenting to the ED). Since leaving the rehab center, he has been feeling weak and does not believe he could take care of himself at home. COVID PCR test performed in the ED resulted as positive. Ultimately he was admitted 12/3/22 - 12/10/22 for what the provider notes as weakness due to mild COVID illness.
1-2 minutes post vaccine rash appeared on neck and arms, throat was itching and slightly swelling. Advised to take Benadryl. 1 week post vaccine elevated temps, rash across arms and chest, worsening fatigue, tachycardia
severe itching elevated BP     skin decoloration    insomnia    itching from arms to neck constantly since  last,year.
Patient presented with chickenpox virus in our office, 1 previous dose of varicella containing vaccine on 2/9/2017.
Hurts a lot; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pain (received 1st dose on an unknown date and experienced pain, refer case US2022AMR053688).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the pain was unknown.   It was unknown if the reporter considered the pain to be related to Shingrix.     Linked case(s) involving the same patient:  US2022AMR053688   Additional Information: GSK Receipt Date: 23-Mar-2022 Reporter's Comments: This case was received from consumer via  interactive digital media.  Additional Supportive Information: The patient self-reported this report. The patient called and stated that received 2 doses of Shingrix and hurts a lot but supposed to be vastly better than the earlier one.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR053688:Same Reporter
I took my second dose of the vaccine (Pfizer) on February 8, 2021. I started to get a headache later that evening and later that night I started to get chills and feel very cold with aches. I was exhausted and still had a headache as well. That morning on the 9th I had to call out, I still felt achy with a headache that lasted all day. I contacted my supervisor and also employee health. I then again had to call out on the 10th because of nausea and a headache that persisted that morning. It wasn't until later that day on the 10th that I felt better than the previous day. I also contacted my supervisor again and employee health.
Extremely swollen lymph node in left armpit-- painful and warm to touch  Have been taking 1000mg of Tylenol every 6 hrs since 2am on August 27th.. woke up in pain
Sore arm; This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Psoriatic arthritis.    No Medical History information was reported.   On 08-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were provided.  In 2021, the patient experienced sore arm.. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. According to the reporter, there was no reasonable possibility of causal association between adalimumab and the event.   No treatment information was provided.
Conjunctivitis and itching within 1 hour of first Hep-B.
On the evening of 4/7, very achy and sore arm and mild fever. Recovered and felt fine by the evening of  4/8.  On 4/12 Began feeling nauseous, and was throwing up all night, along with diarrhea. Severe lower back, knee, hip and outer thigh pain. On morning of 4/13 had a fever of 102°, very nauseous. Still very sore. On 4/14 still achy in lower back and hips and thighs, temperature is closer to normal.
Intermittent but fairly constant migraines beginning the night of and lasting for 3 weeks following vaccine.  On Friday afternoon I noticed pressure behind my right eye, which I attributed to the migraine.  By Sunday midmorning it felt like someone was trying to pry my eyeball out of the socket.  I have a high pain threshold, but the pain was 8.5-10 out of 10.  I called my mom who advised me to take some ibuprofen (I took two 220mg Naproxen tablets).  The pain and pressure diminished for several hours, then came back.  I repeated the dose and had no more problems with my eye after Monday morning.
Patient stated she was immunocompromised and checked that on her consent form.  The Moderna dose for that scenario would be 0.5 ml but the pharmacist seeing the dose #3 was checked changed it to 0.25 ml and gave the 0.25 ml dose without noticing patient had checked she yes on weakened immune system question.  Patient has been called several times but there has no been a return phone call to discuss with the patient.
Widely spread petechial spots on the arms, torso, front and back. Very itchy.
Intense itching all over her body.  Went to doctor and was informed to take Benadryl and pepcid.
Breakthrough case admission after 2 vaccines Moderna 4/16/21 Lot# 038B21A;  Moderna 5/17/21 Lot# 033C21A
On 10/4/11, this employee reports feeling dizziness, headache & general body aches after receiving flu shot on 10/3/2011. She received flu shot at approx 1130AM, worked her shift until 2PM & started H/A so intense she called husband to drive her home as she was unable to walk. On 10/4/11, employee reports feeling better but still has dull H/A. Injection site free of redness/swelling. On 10/5/11, employee reports feeling fine, no H/A or dizziness.
Pain, swelling, redness at injection site. Fever, chills, aches for 3-4 days post injection. Couldn't move left arm for 3-4 days post injection. Pain radiated into neck.
Immediate symptoms - achy, cold like symptoms Beginning May 2021 - three days of seizures and regular convulsions, even during sleep, multiple trips to ER and hospital stays since. Most prevalent symptoms throughout duration include limb weakness and tingling, inability to walk or use limbs, jolts of electricity throughout body, sensory sensitivity (lights and noises), headaches, insomnia, foggy and decreased cognitive ability, throat tightening that impacts swallowing, talking, and breathing, temporary paralysis, dissociative episodes, seizures, slurred speech, and anxiety.
Pt vax w/ 2nd hep B; exp severe local reaction, swelling of arm. Arm was red, warm & painful. Lasted several days and resolved.  No bronchoconstriction observed.
Angioedema; uncontrollable hives\urticaria multiformae; Swelling; Pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ANGIOEDEMA (Angioedema), URTICARIA (uncontrollable hives\urticaria multiformae), SWELLING (Swelling) and PAIN (Pain) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ANGIOEDEMA (Angioedema) (seriousness criteria hospitalization and medically significant), URTICARIA (uncontrollable hives\urticaria multiformae) (seriousness criterion hospitalization), SWELLING (Swelling) (seriousness criterion hospitalization) and PAIN (Pain) (seriousness criterion hospitalization). At the time of the report, ANGIOEDEMA (Angioedema), URTICARIA (uncontrollable hives\urticaria multiformae), SWELLING (Swelling) and PAIN (Pain) outcome was unknown.            Concomitant product was not provided by the reporter. Treatment information was not provided.  The patient reported an adverse reaction to the Moderna booster. Multiple doctors confirmed that this was the cause to her reaction. She had Angioedema, uncontrollable hives, and urticaria multiformae. She could not function in the real world due to the swelling and pain. She had been hospitalized twice due to the severity of her reaction. She is a healthy 25 year old female who never experienced allergies nor changed up her routine. The only change recently was this booster.  . Company comment This spontaneous case concerns a 25-year-old female patient, with no reported medical history, who experienced the unexpected serious (hospitalization) events of ANGIOEDEMA (hospitalization and medically significant), URTICARIA, SWELLING and PAIN, which occurred on an unknown date after receiving third (booster) dose of mRNA-1273 vaccine in an unknown vaccination schedule. Since vaccination date and event date was not provided, latency cannot be assessed. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns a 25-year-old female patient, with no reported medical history, who experienced the unexpected serious (hospitalization) events of ANGIOEDEMA (hospitalization and medically significant), URTICARIA, SWELLING and PAIN, which occurred on an unknown date after receiving third (booster) dose of mRNA-1273 vaccine in an unknown vaccination schedule. Since vaccination date and event date was not provided, latency cannot be assessed. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
shingles; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a elderly female patient who received Herpes zoster (Shingrix) (batch number 7457P, expiry date 20th June 2020) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 7 days after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that the patient developed Shingles 1 week after receiving first dose of Shingrix.
HYPOTENSION ACUTE RESPIRATORY FAILURE HYPOXEMIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY
After the vaccination my child started having large mucusy stools with small amounts of bright red blood in them. She would have 1 or 2 mucusy stools and then a couple normal ones for the first week. The second week the stools became more frequent. She is having at least 1 a day now and it has been going on for 2-3 weeks. She did not have any of these bloody or mucusy stools prior to her vaccination.
C/o headache on day 2 post VZV.  Rash started on 7/1/01 , C/0 of itching - severe, unable to sleep.  Varicella like lesions from worst down covering her legs and feet.  A few on her arm .  None in mouth, though she c/o sore throat MD gave zyrtec and advised aveeno bath
Severe scapular pain that progressed to severe deltoid pain. and that developed to elbow pain over the course of 3 days. Resulting in left index finger numbness and tingling. Still experiencing numbness and tingling and mild pain.
Fri eve 6-4-15 approx. 1800 I developed the following. Increased temp (103 F), chills, bone crushing pain to all joints. Large goose egg area to (L) upper arm. Redness, tender to touch, warm, itching, painful. Occurred after being injected with PREVNAR.
High temp, obtunded, cerebral edema, pt still in hosp w/ dx of encephalitis; viral cultures-negative so far; definite dx has not been established;
Received vaccine at 0830 at 1400 developed numbness on left side of face
Suffer social phobia illness/Dare not meet outside people; This spontaneous case was reported by a consumer and describes the occurrence of SOCIAL ANXIETY DISORDER (Suffer social phobia illness/Dare not meet outside people) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SOCIAL ANXIETY DISORDER (Suffer social phobia illness/Dare not meet outside people). At the time of the report, SOCIAL ANXIETY DISORDER (Suffer social phobia illness/Dare not meet outside people) outcome was unknown. Not Provided          No concomitant medicines were reported No treatment medicines were reported Lower body serotonin level was reported.   Most recent FOLLOW-UP information incorporated above includes: On 02-Dec-2021: Significant Follow Up Appended
Started to develop flu like symptoms cough, fever, body aches, soreness at the injection site, treated with generic TAMIFLU you can buy over the counter.
PATIENT FELT DIZZY, HAD A LITTLE HEADACHE AND WAS SWEATING.
Face and mouth swollen; Face and mouth swollen; Chills; Soak and wet in the night; Tired; Fever sores; Mouth was sore; Fever; Aches, pains; Stiff neck; Soreness of the arm where the vaccine was administered; This is a spontaneous report from a contactable consumer (Patient's parent). A 22-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in right arm on 31Jul2021 10:30 (at 22 years old) as dose 2, single for COVID-19 immunization. Medical history was not reported. There were no concomitant medications. The patient previously received the first dose of BNT162B2 in right arm, on 10Jul2021 10:30 (at 22 years old), for COVID-19 immunization. The patient's parent reported that her son received the second dose of the vaccine on Saturday, 31Jul2021 and had reactions. The patient had a fever. He also had aches, pains, stiff neck, and soreness of the arm where the vaccine was administered. The patient also woke up in the morning of 04Aug2021 with his face and mouth swollen. He had an appointment with the doctor. He had a fever and chills and was soak and wet in the night of 31Jul2021. The stiff neck was not ongoing, but the patient still felt like tired. The patient's parent was wondering if the fever the patient had was so high that it caused the outbreak of the face and everything to swell. The patient's parent stated the patient had fever sores from one side of lip to other. The patient was saying his mouth was sore and woke up and the patient's parent gave him an ice pack and called the doctor. The outcome of the events "face and mouth swollen", and "tired" was not recovered, "aches, pains" was recovering, and unknown outcome for other events.   Information on the batch/lot number has been requested.
Exposed to father with shingles.  Few red spots started 03/17/04 on chest, less than 50 pox sites 03/18/04.
Patient complained of dizziness and was recommended to go to the ER.  Patient did end up going to the ER and complained of dizziness and lightheadedness worse with sitting and standing.  Patient treated for UTI and released from ER with no other treatment.
Patient got sick at work at 5pm, so several hours after the vaccine was given. His daughter states he was coughing and then he fainted.
Patient received a Moderna vaccine at another facility on 05/12/2021. On 05/13/2021, he had chills, fatigue, and myalgias. These symptoms resolved on 05/14/2021. However on 05/14/2021 at 10 AM he developed pleuritic chest pain. He was admitted to hospital on the evening of 05/14/2021 with dramatic elevations in high-sensitivity troponin to 1700 and EKG with diffuse ST elevations and PR depressions, concerning for myopericarditis. He was initially treated with ibuprofen and colchicine. We have ordered an echocardiogram and a cardiac MRI. Workup and treatment are ongoing.
The patient was given 0.1 ml of Pfizer instead of the correct dosage of 0.3ml. This was a vaccinator error and was caught by our pharmacist on site on 3/12/2021.
Fever that reached 105+, complete loss of appetite, severe soreness, pain and a little swelling at injection site, sever chills, severe exhaustion, yet sleepless, restless nights, inconsolable, fever lasted about a week but wasn't back to normal for a month, injection mark was there for about a month too, gave Motrin and Tylenol and had a trip to ER. Fever is gone, but he is still traumatized by it B/C every time near a DR office he freaks. How do you know if he has recovered when you don't know what he would be like with out having the shot.
I do not remember what they were, but it was her 15 month shots.  The morning after she had green coming out of her nose pouring out of her nose and eyes, her eyes were watering so bad l. She has a horrible cough and today went into the doctors again and she now has a double ear infection. She can barely sleep at night, so congested.
The vaccine was reconstituted incorrectly, only 0.8 mL of the diluent was used rather than 1.8 mL.  The patient did receive the recommended dose of 0.3 mL, it was just not the correct strength due to the reconstitution error.  As of this time, no adverse events were reported by the pt.
mom states pt leg begin to swell more than in previous shots about 1PM on 14APR93; mom spplied warm compress cont to swell that noc, took pt to ER pt was adm; fever of 39;